Co-Diagnostics, Inc.
CODX
$1.55
$0.021.31%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -45.69% | -24.86% | -5.96% | -11.62% | -22.34% |
| Total Other Revenue | -93.50% | -100.00% | -94.91% | -51.46% | -45.97% |
| Total Revenue | -84.10% | -93.06% | -89.02% | -47.63% | -42.53% |
| Cost of Revenue | -77.74% | -90.97% | -83.48% | -79.93% | -76.13% |
| Gross Profit | -86.28% | -95.21% | -92.73% | -1.78% | 11.00% |
| SG&A Expenses | -44.58% | -21.39% | -5.12% | -6.29% | -2.36% |
| Depreciation & Amortization | -19.63% | -10.26% | 0.16% | 6.59% | 11.93% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -27.48% | -23.84% | -16.89% | -15.74% | -11.15% |
| Operating Income | 21.95% | 11.17% | -0.13% | 10.79% | 6.15% |
| Income Before Tax | -29.08% | 10.84% | -0.41% | 9.07% | 1.39% |
| Income Tax Expenses | -2,915.33% | -129.50% | -97.83% | 109.41% | 102.07% |
| Earnings from Continuing Operations | -24.59% | 22.05% | 4.20% | 7.79% | -6.53% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -24.59% | 22.05% | 4.20% | 7.79% | -6.53% |
| EBIT | 21.95% | 11.17% | -0.13% | 10.79% | 6.15% |
| EBITDA | 22.03% | 11.20% | -0.13% | 11.31% | 6.68% |
| EPS Basic | 12.91% | 28.92% | 9.66% | 11.96% | -2.98% |
| Normalized Basic EPS | 35.91% | 16.52% | 3.29% | 14.23% | 8.68% |
| EPS Diluted | 12.44% | 28.21% | 9.00% | 11.55% | -2.57% |
| Normalized Diluted EPS | 35.91% | 16.52% | 3.29% | 14.23% | 8.68% |
| Average Basic Shares Outstanding | 31.50% | 11.67% | 6.51% | 4.91% | 3.36% |
| Average Diluted Shares Outstanding | 31.50% | 11.67% | 6.51% | 4.91% | 3.36% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |